• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Bio-Rad Laboratories (NY: BIO )

    358.19 +27.61 (+8.35%)
    Official Closing Price Updated: 7:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Bio-Rad Laboratories

    < Previous 1 2 3 4 5 6 Next >
    Bio-Rad Laboratories: Q4 Earnings Insights
    Via Benzinga
    Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Earnings Scheduled For February 15, 2024
    Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earnings at $0.10 per share on revenue of $188.59 million. 
    Via Benzinga
    Preview: Bio-Rad Laboratories's Earnings
    Via Benzinga
    Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Earnings Outlook For Bio-Rad Laboratories
    Via Benzinga
    Bio-Rad Laboratories Inc. (NYSE: BIO) is a Leading Gainer in Wednesday Morning Trading
    Via Investor Brand Network
    The Latest Analyst Ratings for Bio-Rad Laboratories
    Via Benzinga
    The Latest Analyst Ratings for Bio-Rad Laboratories
    Via Benzinga
    10 S&P 500 Stocks With Over 40% Upside Potential: Hidden Gems Or Value Traps?
    S&P 500 index surges to new highs, driven by AI, earnings optimism, and Fed rate cuts. Top 10 stocks with significant upside potential for 2024 rally. 
    Via Benzinga
    Topics Artificial Intelligence Economy Stocks
    Exposures Artificial Intelligence Interest Rates US Equities
    Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    S&P 500's Hidden Gems: 27 Stocks With 30%+ Upside Potential According To Wall Street Analysts Targets
    Fifty-six percent of S&P 500 companies have shown positive performance in 2023 and 44% retreated Moderna Inc. (NASDAQ: MRNA) offers the highest upside potential (58%). 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Death Cross Looms Over Bio-Rad Laboratories Investors
    Via Benzinga
    Black Friday On Wall Street: 10 S&P 500 Stocks Trading At 40%+ Discount From Analysts' Expectations
    Several S&P 500 stocks are trading at discounts of over 40% compared to analysts' price targets, offering potential upside, but caution is needed. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Clinical Diagnostic-Focused Bio-Rad Stock Trading Lower Today?
    Bio-Rad Laboratories Inc (NYSE: BIO) shares are trading lower after the company lowered its annual revenue growth forecast, citing the uncertain pace of the biopharma sector's recovery and the  
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Bio-Rad Reports Third-Quarter 2023 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    3 Beaten-Down Biotech Stocks Bound for a Bounce Back
    Biotech stocks are still below their post-pandemic peaks. But these beaten-down biotech stocks could lead the sector to new highs. 
    Via InvestorPlace
    Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad Reports Second-Quarter 2023 Financial Results
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Why Are velo Biosciences Stock Is Trading Higher Today?
    Evelo Biosciences Inc (NASDAQ: EVLO) shares are trading higher after the company terminated its sublease agreement with Bio-Rad Laboratories Inc (NYSE: BIO). 
    Via Benzinga
    Bio-Rad Announces New Share Repurchase Program
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Bio-Rad Publishes Corporate Sustainability Report for 2022
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For June 16, 2023
    Via Benzinga
    Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
    From Bio-Rad Laboratories, Inc.
    Via Business Wire
    Top 5 Health Care Stocks That Could Lead To Your Biggest Gains In May
    The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
    Via Benzinga
    < Previous 1 2 3 4 5 6 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.